$98 Million for Stem Cell Therapies for Cancer, Arthritis and More
Directors of the California stem cell agency this week are expected to approve nearly $98 million in awards for early stage clinical trials for treatments of diseases ranging from sickle cell anemia to cancer.
The awards will involve the $3 billion agency's signature disease team program, which is aimed at pushing stem cell research into the marketplace.
…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.